Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Capricor Therapeutics, Inc. (CAPR) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-24.57M |
|
-- |
|
-- |
|
$26.28M |
|
$-26.28M |
|
$1.71M |
|
$-24.57M |
|
$-24.56M |
|
$-24.57M |
|
$-24.57M |
|
$-24.57M |
|
$-24.56M |
|
$-26.28M |
|
$-25.79M |
|
45.72M |
|
45.72M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$100.95M |
|
$11.07M |
|
$25.49M |
|
$126.44M |
|
$28.15M |
|
-- |
|
$14.42M |
|
$42.57M |
|
$83.87M |
|
$83.87M |
|
$83.87M |
|
45.72M |
|
| Cash Flow Statement Financials | |
$-46.24M |
|
$54.39M |
|
$0.08M |
|
$11.29M |
|
$19.51M |
|
$8.22M |
|
$13.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.59 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-52.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.30% |
|
-29.30% |
|
-19.43% |
|
-29.30% |
|
$1.83 |
|
$-1.16 |
|
$-1.01 |
|